The Timken
TKR
114.91
-4.63
-3.87%
The Timken
US · TKR
#1618 by market cap
Listed 1970
114.91
-4.63
-3.87%
Live - 5344 symbols - heartbeat 151s ago
· 2026-10-08 08:28
Pre-market
114.68
-0.20%
After-hours
115.30
+0.34%
- Market cap
- 7.96B
- P/E (TTM)i
- 31.14
- P/Bi
- 2.49
- EPSi
- 4.11
- Div yieldi
- 1.23%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on TKR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.26, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.19% YoY
Margins
- Gross margin
- 30.41%
- Operating margin
- 12.35%
- Net margin
- 6.29%
Key ratios & quality
- Enterprise valuei
- 9.55B
- Altman Z-Scorei
- 3.26
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.58B | 3.79B | 3.51B | 4.13B | 4.50B | 4.77B | 4.57B | 4.58B |
| Gross profit | 1.04B | 1.14B | 1.01B | 1.15B | 1.33B | 1.51B | 1.44B | 1.39B |
| Selling & admin expenses | 580.70M | 618.60M | 533.80M | 580.50M | 637.10M | 740.80M | 752.00M | 748.30M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 459.40M | 523.20M | 476.10M | 522.00M | 651.00M | 702.60M | 610.70M | 565.90M |
| Pretax profit | 408.10M | 472.40M | 396.30M | 476.60M | 550.90M | 530.50M | 494.20M | 416.00M |
| Tax | 102.60M | 97.70M | 103.90M | 95.10M | 133.90M | 122.50M | 118.90M | 98.70M |
| Net profit | 305.50M | 374.70M | 292.40M | 381.50M | 417.00M | 408.00M | 375.30M | 317.30M |
| Basic EPS | 4 | 5 | 4 | 5 | 6 | 6 | 5 | 4 |
| Diluted EPS | 3.86 | 4.71 | 3.72 | 4.79 | 5.48 | 5.47 | 4.99 | 4.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.14B | 1.17B | 1.16B | 1.11B | 1.23B | 1.26B |
| Gross profit | 358.70M | 360.30M | 349.00M | 325.30M | 394.00M | 399.30M |
| Selling & admin expenses | 184.80M | 189.70M | 186.40M | 187.40M | 201.20M | 205.90M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 154.90M | 150.70M | 142.40M | 117.90M | 172.20M | 172.70M |
| Pretax profit | 118.30M | 116.40M | 107.50M | 73.80M | 142.90M | 57.90M |
| Tax | 26.90M | 30.70M | 33.20M | 7.90M | 37.00M | 20.70M |
| Net profit | 91.40M | 85.70M | 74.30M | 65.90M | 105.90M | 37.20M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 0 |
| Diluted EPS | 1.11 | 1.12 | 0.99 | 0.89 | 1.40 | 0.41 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.74B | 1.87B | 2.00B | 2.21B | 2.50B | 2.63B | 2.52B | 2.60B |
| Cash & ST investments | 132.50M | 209.50M | 320.30M | 257.10M | 331.60M | 418.90M | 373.20M | 364.40M |
| Inventory | 835.70M | 842.00M | 841.30M | 1.04B | 1.19B | 1.23B | 1.20B | 1.24B |
| Total assets | 4.45B | 4.86B | 5.04B | 5.17B | 5.77B | 6.54B | 6.41B | 6.68B |
| Total current liabilities | 685.60M | 736.60M | 848.00M | 896.60M | 1.01B | 1.47B | 820.50M | 922.10M |
| Short-term debt | 43.00M | 110.30M | 157.90M | 80.00M | 73.10M | 631.50M | 45.00M | 72.00M |
| Long-term debt | 1.64B | 1.65B | 1.43B | 1.41B | 1.91B | 1.79B | 2.05B | 1.88B |
| Total liabilities | 2,802,500,000.00 | 2,905,100,000.00 | 2,816,400,000.00 | 2,793,000,000.00 | 3,419,500,000.00 | 3,839,300,000.00 | 3,426,900,000.00 | 3,331,100,000.00 |
| Total equity | 1.64B | 1.95B | 2.23B | 2.38B | 2.35B | 2.70B | 2.98B | 3.35B |
| Retained earnings | 1.63B | 1.91B | 1.34B | 1.62B | 1.93B | 2.23B | 2.49B | 2.68B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.62B | 2.72B | 2.73B | 2.60B | 2.76B | 2.84B |
| Cash & ST investments | 376.10M | 419.30M | 449.10M | 364.40M | 344.70M | 399.10M |
| Inventory | 1.20B | 1.22B | 1.23B | 1.24B | 1.27B | 1.25B |
| Total assets | 6.57B | 6.81B | 6.80B | 6.68B | 6.88B | 6.83B |
| Total current liabilities | 831.70M | 869.70M | 879.20M | 922.10M | 956.90M | 918.30M |
| Short-term debt | 54.10M | 91.10M | 54.10M | 72.00M | 76.60M | 73.30M |
| Long-term debt | 2.11B | 2.14B | 2.09B | 1.88B | 2.03B | 2.04B |
| Total liabilities | 3,481,400,000.00 | 3,541,100,000.00 | 3,505,100,000.00 | 3,331,100,000.00 | 3,513,600,000.00 | 3,462,500,000.00 |
| Total equity | 3.09B | 3.27B | 3.30B | 3.35B | 3.37B | 3.36B |
| Retained earnings | 2.54B | 2.60B | 2.64B | 2.68B | 2.75B | 2.76B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 332.50M | 550.10M | 577.60M | 387.30M | 463.80M | 545.20M | 475.70M | 554.30M |
| Depreciation & amortization | 146.00M | 160.60M | 167.10M | 167.80M | 164.00M | 201.30M | 221.80M | 230.10M |
| Free cash flow | 219.90M | 409.50M | 456.00M | 239.00M | 285.40M | 357.40M | 305.70M | 406.10M |
| Dividends paid | -85.70M | -84.90M | -87.00M | -92.20M | -91.70M | -94.00M | -96.10M | -98.30M |
| Stock buybacks / issuance | -98.50M | -62.70M | -49.30M | -93.00M | -211.60M | 33.90M | 191.80M | -57.40M |
| Ending cash balance | 133.10M | 216.20M | 321.10M | 257.90M | 340.70M | 419.30M | 373.60M | 365.40M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 58.60M | 111.30M | 201.10M | 183.30M | 39.30M | 107.10M |
| Depreciation & amortization | 55.10M | 57.20M | 58.60M | 59.20M | 58.90M | 59.70M |
| Free cash flow | 23.40M | 78.20M | 163.80M | 140.70M | 500.00K | 80.50M |
| Dividends paid | -25.10M | -24.40M | -24.40M | -24.40M | -25.30M | -25.00M |
| Stock buybacks / issuance | -23.10M | -22.60M | 0 | -11.70M | -28.00M | -20.00M |
| Ending cash balance | 376.50M | 420.80M | 451.50M | 365.40M | 345.50M | 400.50M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 20.04 | 21.00 | 14.15 | 16.60 | 17.86 | 16.25 | 13.04 | 9.60 |
| ROA %i | 7.72 | 7.78 | 5.75 | 7.23 | 7.45 | 6.40 | 5.45 | 4.41 |
| ROIC %i | 12.00 | 11.94 | 8.82 | 10.78 | 11.27 | 10.04 | 8.65 | 7.12 |
| 5-year avg ROE %i | 13.38 | 15.96 | 16.19 | 17.35 | 17.93 | 17.17 | 15.58 | 14.67 |
| EBIT margin %i | 12.84 | 14.37 | 13.20 | 12.95 | 13.91 | 13.45 | 13.54 | 11.49 |
| FCF / sales %i | 6.14 | 10.81 | 12.98 | 5.78 | 6.35 | 7.49 | 6.68 | 8.86 |
| Current ratioi | 2.53 | 2.54 | 2.36 | 2.47 | 2.47 | 1.79 | 3.07 | 2.82 |
| Quick ratioi | 1.16 | 1.20 | 1.19 | 1.10 | 1.12 | 0.84 | 1.44 | 1.29 |
| Debt / assetsi | 37.83 | 37.65 | 33.07 | 30.34 | 35.56 | 38.22 | 33.98 | 30.79 |
| LT debt / equityi | 103.74 | 92.04 | 70.11 | 64.87 | 87.26 | 72.37 | 75.49 | 62.30 |
| Interest coveragei | 8.89 | 7.55 | 6.86 | 9.11 | 8.38 | 5.79 | 4.95 | 4.77 |
| Revenue CAGR (3Y) %i | 7.63 | 12.39 | 5.36 | 4.90 | 5.87 | 10.72 | 3.43 | 0.63 |
| Net income CAGR (3Y) %i | 17.09 | 37.01 | 11.83 | 6.82 | 4.01 | 11.47 | -1.50 | -10.88 |
| FCF CAGR (3Y) %i | -7.15 | 15.41 | 51.13 | 2.82 | -11.34 | -7.80 | 8.55 | 12.48 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.85 | 10.52 | 9.80 | 9.60 | 10.07 | 8.23 |
| ROA %i | 4.99 | 4.63 | 4.38 | 4.41 | 4.58 | 3.79 |
| ROIC %i | 7.95 | 7.42 | 7.00 | 7.12 | 7.23 | 6.09 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.79 | 12.24 | 11.98 | 11.49 | 11.74 | 10.22 |
| FCF / sales %i | 7.16 | 6.97 | 8.59 | 8.86 | 8.20 | 8.10 |
| Current ratioi | 3.15 | 3.13 | 3.11 | 2.82 | 2.88 | 3.10 |
| Quick ratioi | 1.54 | 1.56 | 1.55 | 1.29 | 1.37 | 1.52 |
| Debt / assetsi | 34.22 | 34.00 | 32.93 | 30.79 | 32.02 | 32.28 |
| LT debt / equityi | 75.20 | 71.91 | 69.73 | 62.30 | 66.30 | 66.69 |
| Interest coveragei | 4.85 | 4.82 | 4.88 | 4.77 | 5.08 | 4.66 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Engineered Bearings is the largest reported line at 64.00% of revenue, across 2 reported segments.
- Industrial Motion follows at 36.00%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Engineered Bearings64.00%
Industrial Motion36.00%
Quote time 2026-10-08 08:28:28 · For reference only, not investment advice and not tailored to your situation.